Scarica l'app Stockscreener
18.19
2.19%
0.39
Upstream Bio Inc Borsa (UPB) Ultime notizie
Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference - GlobeNewswire
Upstream Bioprocessing Industry Analysis and Forecast, - GlobeNewswire
Upstream Bio, Inc.’s (NASDAQ:UPB) Quiet Period Set To End on November 20th - Defense World
Upstream Bio, Inc.'s (NASDAQ:UPB) Quiet Period Set To End on November 20th - MarketBeat
Brokers Set Expectations for Upstream Bio Q4 Earnings - MarketBeat
Upstream Bio Advances Clinical Trials, Strengthens Financials - TipRanks
Tezspire Phase III Nasal Polyp Data May Lead To Second Indication - Scrip
William Blair Weighs in on Upstream Bio Q4 Earnings - Defense World
Upstream Bio Inc (UPB) Quarterly 10-Q Report - Quartz
Upstream Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire
FMR LLC Acquires New Stake in Upstream Bio Inc - GuruFocus.com
Severe Asthma Clinical Trial Pipeline Appears Robust With 40+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Malaysian Reserve
Upstream Bio initiated with an Overweight at Piper Sandler - MSN
Arrivent Biopharma Inc (AVBP-Q) QuotePress Release - The Globe and Mail
Here are Tuesday's biggest analyst calls: Apple, Microsoft, Palantir, Eli Lilly, Broadcom, Krispy Kreme, Live Nation & more - Head Topics
Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say - Benzinga
Upstream Bio initiated with an Overweight at JPMorgan - MSN
This Eaton Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Piper Sandler Begins Coverage on Upstream Bio (NASDAQ:UPB) - MarketBeat
TD Cowen bullish on Upstream Bio, bets on differentiated asthma treatment verekitug - Investing.com
Piper Sandler sees big potential for Upstream Bio asthma therapy, Overweight on stock - Investing.com UK
Upstream Bio prices IPO at $17 per share - MSN
Finance Watch: Septerna Raises $288m In Public Market Debut - Citeline News & Insights
Septerna Shares Jump 19% After IPO Shows Biotech Still Hot - Bloomberg
CeriBell Shares Rise 47% to Lead Trio of Life Sciences IPOs - MSN
Goldman-backed drug developer Septerna raises $288 mln in US IPO - Reuters
Upstream Bio stock rallies 32% following upsized $255M IPO - MSN
Upstream Bioprocessing Market Forecast 2024: Key Global Developments - openPR
Upstream Bio Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Upstream Bio Rings the Opening Bell - Nasdaq
Warren Buffett and Biotech IPOs Highlight Recent Insider Buying - 24/7 Wall St.
Insider Trading Recap: Thursday's Top Buys and Sells in US Stocks - Investing.com
OrbiMed Advisors LLC purchases $14 million in Upstream Bio shares - Investing.com India
Orbimed Advisors LLC Acquires New Stake in Upstream Bio Inc - Yahoo Finance
OrbiMed Advisors LLC purchases $14 million in Upstream Bio shares By Investing.com - Investing.com Nigeria
Upstream bio director Erez Chimovits buys $14 million in shares By Investing.com - Investing.com South Africa
Upstream bio director Erez Chimovits buys $14 million in shares - Investing.com
Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - The Manila Times
Chronic Rhinosinusitis with Nasal Polyps Market Expected - openPR
Upstream Bio and Camp4 and Ceribell Transactions - William Blair
Upstream Bio shares soar in impressive IPO - The Pharma Letter
Opening Day: Another trio of biotech IPOs make Friday debut - Yahoo Finance
HBM portfolio company Upstream Bio raises USD 255 million in successful initial public offering - Marketscreener.com
1.89%
2.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):